Skip to main content
Premium Trial:

Request an Annual Quote

Focus Diagnostics Licenses Evogen PCR Probe Technology

NEW YORK (GenomeWeb News) – Evogen has granted Focus Diagnostics a license to incorporate Evogen's HyBeacons PCR probe technology into Focus' molecular diagnostic products and services, the firms announced today.

HyBeacons probes are sequence-specific hybridization probes that contain two fluorophores per probe. Because HyBeacons are not hydrolyzed during PCR amplification, "positive confirmation of the amplicon is available by way of high definition melt curve analysis," according to the companies. They added that the technology provides "clear quantitative data" during amplification and has "proven capabilities with DNA and RNA targets."

Financial and other terms of the deal were not disclosed.

Evogen develops High Definition PCR molecular diagnostic systems and is based in Lenexa, Kan. Focus is a Quest Diagnostics business headquartered in Cypress, Calif., and develops molecular and immunology products, including the Simplexa line of molecular tests.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.